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Microscale thermophoresisChemical denaturant titrations can be used to accurately determine protein stability. However, data acquisition is
typically labour intensive, has low throughput and is difﬁcult to automate. These factors, combined with high
protein consumption, have limited the adoption of chemical denaturant titrations in commercial settings. Thermal
denaturation assays can be automated, sometimes with very high throughput. However, thermal denaturation
assays are incompatible with proteins that aggregate at high temperatures and large extrapolation of stability
parameters to physiological temperatures can introduce signiﬁcant uncertainties. We used capillary-based instru-
ments to measure chemical denaturant titrations by intrinsic ﬂuorescence and microscale thermophoresis. This
allowed higher throughput, consumed several hundred-fold less protein than conventional, cuvette-based
methods yet maintained the high quality of the conventional approaches. We also established efﬁcient strategies
for automated, direct determination of protein stability at a range of temperatures via chemical denaturation,
which has utility for characterising stability for proteins that are difﬁcult to purify in high yield. This approach
may also have merit for proteins that irreversibly denature or aggregate in classical thermal denaturation assays.
We also developed procedures for afﬁnity ranking of protein–ligand interactions from ligand-induced changes in
chemical denaturation data, and proved the principle for this by correctly ranking the afﬁnity of previously unre-
ported peptide–PDZ domain interactions. The increased throughput, automation and low protein consumption
of protein stability determinations afforded by using capillary-based methods to measure denaturant titrations,
can help to revolutionise protein research. We believe that the strategies reported are likely to ﬁnd wide applica-
tions in academia, biotherapeutic formulation and drug discovery programmes.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
1.1. Protein denaturation: principles and applications
Equilibrium denaturation experiments are widely used to quantify
how changes in pH, temperature, or the presence of different additives
affect protein stability [1–7]. These experiments yield insights into the
forces driving protein folding and misfolding dynamics, and their linkage
with function and disease [8–12]. Moreover, protein stability is of directnative ensemble; D, denatured
ion spectroscopy; CD, circular
; DSC, differential scanning calo-
o-Bowman series 2 spectroﬂuo-
uson).
. This is an open access article underrelevance to optimising the formulation and storage of clinical antibodies
and biotherapeutic proteins (see Section 3.3) [1–3].
When quantifying the relative stability of the native protein (N), the
denatured state (D) is typically used as a reference state [5]. The relative
population of different states under speciﬁc conditions deﬁnes the equi-
librium constant (Keq). The difference in free energy between D and N
(i.e. GD − GN, Fig. S1a), can be calculated from ΔGD–N = −RT·lnKeq
(where R is the gas constant and T the temperature) [9,13,14]. Equi-
librium denaturation measurements are exceptionally powerful when
combinedwith systematic proteinmutagenesis (the ‘protein engineering
method’) [5,8,15,16]. This allows changes inΔGD–N for amutant protein to
be compared to the wild-type value (ΔΔGD–N, Fig. S1a) and can yield
atomic resolution insights into the origins of protein folding and stability,
but typically requires the stability of 40–100 protein variants to be deter-
mined [17,18].
Protein denaturation can be mediated using mechanical, thermal or
chemical methods. Mechanical methods involve stretching a proteinthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Fig. 1. Chemical denaturation of a protein at equilibrium. Simulated 2-state denaturation
induced by increasing the chemical denaturant concentration. The spectroscopic signal
used to probe denaturation is typically sigmoidal (black triangles) and consistent with co-
operative unfolding [13,14,16]. In order to determine the fractional occupancy of native
and denatured states, it is necessary to ﬁt the slopes of pre- (native) and post-transition
(denatured) baselines to linear functions (dashed lines). The ΔGD−N0 value can be easily
determined by linear extrapolation once the transition midpoint ([Denaturant]50%) and
mD–N values are known (see Eq. (1), see Section 1.1). mD–N correlates with the slope of
the transition (grey line) and increases with protein size (Fig. S1b) [13,23].
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methods provide unique insights, they are technically challenging and
require highly specialised, expensive instrumentation (which has limit-
ed their widespread adoption). Thermal denaturation methods involve
gradually heating samples whilst recording changes in experimental
parameters that discriminate the properties (and populations) of native
and denatured conformers. Differential scanning calorimetry (DSC), cir-
cular dichroism (CD) and nuclear magnetic resonance (NMR) spectros-
copy are popular, gold standard analytical techniques for probing thermal
denaturation (although CD and NMR are not thermal denaturation
methods per se and are more routinely used for making measurements
at a single temperature) [6,7,19]. The need for gradual heating means
that thermal denaturation experiments cantake several hours, even
when employing robotic platforms. Differential scanning ﬂuorimetry
(DSF) and isothermal denaturation (ITD) are thermal denaturation
methods commonly used to screen protein–ligand interactions from
changes inmelting temperature (Tm, as in DSF) or the kinetics of denatur-
ation (as in ITD) [1,2,20]. Very high throughput can be achieved in DSC
and ITD experiments by multiplexing the measurements (e.g. making
many measurements in parallel using 384-well microtitre plates) [1,2,
20]. Highpercentages are amenable to thermal denaturation assays. How-
ever, this technique is not universally applicable, as some proteins aggre-
gate irreversibly at elevated temperatures, which precludes rigorous
thermodynamic analyses (since a true equilibrium cannot be established
under such circumstances).Whilst protein stability can often be accurate-
ly determined at themelting temperature (Tm), signiﬁcant extrapolations
to lower, physiological temperatures (e.g. for a thermostable proteins
with a high Tm value) can introduce considerable errors into ΔGD–N [3,6,
13,21].
More proteins denature reversibly in chemical denaturant titrations
than in thermal denaturation experiments [3,21]. For example, Freire
et al. have measured the anti-EGFR monoclonal antibody using DSC and
showed that the data from an initial thermal denaturationwere not reca-
pitulated upon subsequent re-scanning [3]. By contrast, chemical dena-
turation of anti-EGFR antibody with urea was highly reproducible
before or after denaturation with 9 M urea [3]. This high incidence of
reversibility, combined with chaotropes being cheap and compatible
with many buffers, makes chemical denaturation the academic's pre-
ferred method for measuring protein stability [22]. Chaotropes, such as
urea or guanidinium chloride (GdmCl), have been empirically shown to
vary ΔGD–N in a quasi-linear manner by selectively stabilising denatured
conformers Eq. (1) [7,13,14,23]:
ΔGD−N ¼ ΔG0D−N−mD−N  Denaturant½  ð1Þ
whereΔGD−N0 is protein stability in the absence of a denaturant andmD–N
is derived from the gradient of the unfolding transition (which correlates
with changes in accessible surface area accompanying denaturation
(Fig. S1b)) [13,14,23]. Thus, ΔGD–N may be determined by varying the
denaturant concentration and observing the relative changes in the pop-
ulations of N and D (Fig. 1).
In equilibrium denaturant titrations, the target protein (at a ﬁxed
concentration) is titrated into increasing chaotrope concentrations.
Solutions are extensively equilibrated to ensure that the system reaches
equilibrium, including cis–trans isomerisation of proline residues [8,24].
Each point of this titration is measured using a technique that distin-
guishes N from D (see Table 1), yielding sigmoidal curves for 2-state re-
actions (where only N and D are signiﬁcantly populated, Fig. 1) [16].
However, researchers are typically interested in protein stability in the
absence of denaturant (ΔGD−N0 ), which can be simply calculated from
ΔGD−N0 = mD − N ⋅ [Denaturant]50 % (since ΔGD–N equals zero at the
transition midpoint, [Denaturant]50%, see Eq. (1)) [13,14,23,24]. Whilst
[Denaturant]50% is generally the most robustly determined parameter,
it is more challenging to accurately determine mD–N (especially for
large proteins where transition regions are narrow, Fig. S1b) [25].
Thus, high data densities are frequently used to improve curve ﬁttingprecision (Fig. 1). Differences in stability between proteins, or mutants
of the same protein, are generally assumed to be signiﬁcant if ΔΔGD–N
is ≥0.5 kcal/mol [5,10,15,18]. However, whilst this is a widely used
threshold within the protein folding community, other values may be
applicable depending on themD–N values under study (since large pro-
teins have largermD–N values and more precise [Denaturant]50% values
than smaller proteins, which have smallermD–N values and less precise
[Denaturant]50% values (Fig. S1)).
The most commonly used techniques for chemical denaturant titra-
tions are intrinsic ﬂuorescence emission spectroscopy (FES), circular
dichroism (CD) and NMR spectroscopy (Table 1) [19,26]. Chemical
denaturant titrations involve 30–50 samples (typically with volumes of
0.2–1.0 ml) being sequentially loaded by hand into cuvettes and there-
after thermostated for a deﬁned duration beforemakingmeasurements.
Thus, these experiments are repetitive and take skilled operators 2–4 h
to complete (Table 1). Whilst CD and FES spectrometers can be daisy-
chained with auto-titrators, these devices consume more protein than
manual titrations and offer no real speed advantage (since proteins
must be fully equilibrated between denaturant injections for a true equi-
librium to be established).
Plate readers can accelerate themeasurement of chemical denaturant
titrations and reduce sample consumption to as low as 5–10 μl per data
point (especially when a covalently attached ﬂuorophore with a high
quantum yield is used to probe protein denaturation). However, our ex-
perience is that even quartz plates have variations in plate geometry
and sample menisci that cause unacceptable data scatter in denaturant
titrations (NF, CMJ, unpublished data). Furthermore, injudicious use of
extrinsic ﬂuorescent probes can affect the stability of protein targets or
introduce unwanted experimental complications [27–29]. For example,
extrinsic labelling of proteins can, in some cases, be problematic, requiring
protein engineering to provide a suitable residue to which ﬂuorescent
dyes can be covalently coupled and it can be time-consuming to separate
labelled and unlabelled proteins. Despite the clear advantages of chemical
denaturant titrations, their tediousness and relatively high protein con-
sumption has historically prevented their widespread adoption in com-
mercial settings.
1.2. Overview of microscale thermophoresis and associated instrumentation
Here we report strategies that greatly simplify and accelerate equilib-
rium denaturant titrations, without compromising data quality. We used
capillary-based instrumentation to measure denaturant titrations in two
ways (Fig. 2): (i) using sensitive label-free instruments as low-volume
ﬂuorimeters to detect intrinsic ﬂuorescence emission changes
Table 1
Common techniques used to measure chemical denaturant titrations.
NMR Far-UV CD Cuvette-based FES NT.LabelFree FES NT.LabelFree
thermophoresis
Probes 13C, 15N or 1H nuclei Secondary structure Tertiary structure Tertiary structure Solvation shell
Typical [protein] 50 μM–5 mM 5–100 μM 0.5–100 μM 0.1–100 μM 2–20 μM
Sample vol. per titrationa 5–10 ml 8–15 ml 16–50 ml 0.2–0.5 ml 0.2–0.5 ml
Total sample per titration 15–30 mg 1–2 mg 0.5–1 mg 5–10 μga 5–10 μgb
Time per titration 1–3 days 2–4 h 2–3 h 25 min 45–60 minc
Sample limitations Proteins usually small
(typically b30 kDa)
Avoid proteins with
weak signal changes
Non-ﬂuorescent
proteins invisible
Non-ﬂuorescent
proteins invisible
Works best for slow
folding proteins
Automation Automated sample
changers available
User input needed
for each sample
User input needed
for each sample
Semi-automated.
No washing steps
Semi-automated.
No washing steps
Buffer limitations Avoid protonated buffers
in 1H NMR (e.g. Tris)
Avoid chiral buffers
(e.g.MES, DTT)
All buffers suitable All buffers suitable All buffers suitable
Additional comments Expensive isotope-enriched
protein samples are needed.
Yields atomic resolution insights
Chaotropes or buffers can
limit the dynamic range
of CD instruments
Extrinsic dyes can be used
as reporters (but may
perturb stability).
Probes chemical and thermal
denaturation. ΔGD–N vs. T
measured directly
Excellent for ligand binding.
Quality control: aggregates
visible in raw data
a Assuming titrations employ different samples for each denaturant concentration, which is by far the most widely used strategy for chemical denaturant titrations.
b Assuming similar protein concentrations to those employed here (~2 μM).
c For titrations containing 48 data points (i.e. 3 × 16 distinct denaturant concentrations measured using Monolith NT.LabelFree instrument, see Materials and methods).
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using microscale thermophoresis (MST) [30–32]. Microscale
thermophoresis (MST) describes the directed movement of molecules
along μm-sized temperature gradients [30–32]. The movement of pro-
teinmoleculeswithin a small focal volumeon this temperature gradient
may be followed by either the extrinsic ﬂuorescence of a covalently at-
tached ﬂuorophore or, in the case of the label-free instruments used
here, intrinsic ﬂuorescence emitted by tryptophan residues (Fig. 2)
[30–32].
MST reports on factors affecting solvation entropy of the ﬂuorescent
molecule (including changes in size, conformation and charge) [30–32].
Consequently, MST is typically used to quantify molecular interactions,
since binding of a ligand alters at least one of these physical parameters.
As a protein's solvation shell is signiﬁcantly affected by denaturation,
MST can also be used to detect protein unfolding [10]. However, given
that protein folding is usually accompanied by changes in the emission
of tryptophan ﬂuorescence, label-free MST instruments allow denaturant
titrations to also be measured using intrinsic ﬂuorescence emission.
Importantly, capillary-based denaturant titrations can be measured
5–30 times faster, whilst consuming 40–200 times less protein than
existing cuvette-based approaches (including CD and ﬂuorescence
spectrometers, Table 1). Further, measurements using capillary-based
instruments are semi-automated, allowing a single operator to performFig. 2. Layout of themicroscale thermophoresis instrument andmeasurement principles. (A)MST
ature is regulated by thermal elements which directly contact these capillaries. A focused IR laser i
thermophoretic movement of molecules [30,31]. Fluorescent molecules in the capillary are excite
cence of molecules in solution (yellow dots) is detected over time. For simple FES experiments, de
infrared laser is activated after 5 s, resulting in thermophoresis towards lower temperatureswhich
shown here), or ﬂuorescence increases (negative thermophoresis). After a deﬁned time, the infra25–50 titrations per day. They can also automatically re-measure chem-
ical denaturant titrations over a range of temperatures, allowing the
temperature-dependence of thermodynamic parameters to be deter-
mined hands-free and without exposing proteins to the high tempera-
tures that can cause aggregation in some proteins. We also show that
our approach can also be used to screen for ligand-induced changes in
protein stability, which has value for therapeutic targets or potentially
proteins that behave badly in thermal denaturation screening assays
(although this will require further work to verify) [3,30,31]. We believe
that these advances in throughput, material consumption and ease-of-
use can help to revolutionise protein research in academic and com-
mercial settings.
2. Materials and methods
2.1. Reagents
Ultrapure urea and guanidinium chloride were purchased from MP
Biomedicals (CA, USA). All other reagents were purchased from Sigma
Chemical Co. (MO, USA) or ThermoFisher (MA, USA). The C-amidated,
N-acetylated AWPAK peptide was synthesised by ChinaPeptides
(Shanghai, China). SOD1 H43Y noloops and Escherichia coli cytochrome
b562 F65W proteins were donated by Mikael Oliveberg (Universityis measured in disposable capillaries that hold sample volumes of ~4 μl. The sample temper-
nduces a local temperature gradient in the sample (typically in the order of 2–6 K), triggering
d and detected through the same objective lens. (B) During an MST experiment, the ﬂuores-
tection of the initial ﬂuorescence for 1–5 s is sufﬁcient. During a typical MST experiment, the
can be quantiﬁed bymeasuring theﬂuorescence decay (in case of positive thermophoresis, as
red laser is switched off, resulting in re-equilibration of the solution by diffusion.
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α-Spectrin expression vectors were gifts from Jane Clarke (Cambridge
University). LQRRRETQV and LQRRRETQ-Abu peptides and the PDZ1 ex-
pression vector were gifts from Per Jemth (Uppsala University). Barley
chymotrypsin inhibitor-2 (CI2), murine FBP28 WW domain, hepatitis B
core protein, the PDZ1 of the post-synaptic density protein 95 (PSD-95)
with the F95Wmutation (PDZ1 F95W) and α-spectrin constructs were
expressed and puriﬁed as reported [10,16,33,34]. Protein concentrations
were determined spectrophotometrically from calculated molar extinc-
tion coefﬁcients.2.2. Denaturant titrations
Buffers for denaturant solutions (Table S2) were prepared gravimetri-
cally in volumetric ﬂasks to avoid inaccuracies caused by denaturant
effects on pH electrodes. Buffered denaturant stocks were prepared simi-
larly and contained urea or GdmCl at concentrations close to their solubil-
ity limits (~10M and 8M, respectively). Denaturant concentrations were
accurately determined using refractometry. Concentrated proteins (in the
same buffers) were then diluted into buffered denaturant-free or dena-
turant stocks (see Table S2). These solutions were thoroughly mixed
(by pipetting) and equilibrated for at least 1 h before measurements (to
allow complete equilibration). This procedure yielded titrations with up
to 48 different denaturant concentrations. To characterise the effect of
peptide binding on the stability of PDZ1 F95W, a constant volume of
water or peptidewas added to protein-containing stocks before pipetting
the titration.2.3. Spectroscopic measurements
Far-UV CD spectroscopy was performed using a Jasco J810 spectropo-
larimeter (Jasco, MD) and 1mmpathlength cuvettes (Hellma, Germany).
The ellipticity of a 70 μMSOD1 sample at 215 nmwasmeasured 60 times
(over 1min) to yield amean ellipticity value for each denaturant concen-
tration. The ellipticity at 222 nm of a 10 μMsample of the P60Amutant of
theR16α-spectrin domainwas recorded from293 to368K toprobe ther-
mal denaturation (using a scan rate of 0.1 K/min). Fluorescence emission
measurements were made using an Aminco-Bowman SLM2 spectrome-
ter (ThermoFisher, MA) and a 4 × 10 mm pathlength cuvette (Hellma,
Germany, excitation and emission pathlengths, respectively). Intrinsic
ﬂuorescence was excited at 280 nm (2.5 nm slit-width) and emission re-
corded twice between 300 and 400 nm (2.5 nm slit-width, 60 nm/min
scan rate). The averaged intensity at a given wavelength was plotted vs
denaturant concentration to yield denaturant titrations.2.4. Intrinsic ﬂuorescence emission studies using MST instrumentation
Measurementswere performed using aMonolith NT.LabelFree instru-
ment (NanoTemper Inc., Germany). ~4 μl of each sample was aspirated
into standard-treated glass capillaries by capillarity (NanoTemper Inc.,
Germany). Capillaries were loaded into a 16-capillary sample holder
and thermostated inside the instrument (at 298 K, unless stated other-
wise) for ~5 min before measurements. The excitation at 280 nm
(20 nm bandwidth) was optimised by varying the LED power (from 3
to 25%, Table S2) to yield emission intensities from 330 to 380 nm of
6000–25,000 A.U. This intensity was always N500 A.U. above background
signal intensity. Intrinsic ﬂuorescence was measured for 1–5 s in the
absence of a heat gradient. Capillaries were loaded into the instrument
as three sets of 16 point titrations (to yield a ﬁnal titration with up to 48
denaturant concentrations). To avoid systematic errors, these sets were
taken from intercalated points in each complete titration (i.e. the ﬁrst
data set contained data points 1, 4, 7…etc., whereas the second set
containeddata points 2, 5, 8..... etc.). This procedure yielded excellent titra-
tions for most of the proteins that we examined.2.5. Thermophoresis measurements
Thermophoresis measurements for SOD1 or the AWPAK peptide
were performed as described above (also see Table S2), but employing
thermal gradients of 2–6 K. Gradients were induced by an infra-red
laser using laser powers of 30% (SOD1) or 20–80% (AWPAK peptide)
[31]. Fluorescence emission was recorded for 5 s before and after the
laser was switched on (Fig. 4B), with data collection throughout. The
temperature gradient was maintained for ~30 s. Data were normalised
to an arbitrary initial ﬂuorescence value of 1. Thermophoresis is the
ratio of normalised signals between two time-points after switching
the laser on (typically ~1 and ~29 s, with data averaged within a 0.5–
1 s window at each time-point). Normalised values were multiplied
by 1000 by the instrumental software.
MST was used to measure the interaction between PDZ1 F95W and
peptides. A 1 mM peptide stock was serially diluted (1:1) with 50 mM
Tris buffer pH 7.5, 150 mM NaCl, 10 mM MgCl2, 0.05% (v/v) Tween to
yield a titration containing sixteen peptide concentrations. PDZ1 F95W
was then added at a ﬁnal concentration of 5 μM and thermophoresis
measured in MST-grade standard-treated capillaries at 298 or 310 K.
Thermophoresis was induced using laser powers of 20% (at 310 K) or
40% (at 298 K). Thermophoresis was deﬁned as the ratio of signals within
a 1 s timewindow ~1 s and ~20 s after the laser was switched on. The ti-
trations were ﬁt to Eq. (2) using the manufacturer's software.
Signal ¼ U þ B−U
2  P½   P½  þ L½  þ Kd−
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
P½  þ L½  þ Kdð Þ2−4  P½   L½ 
q 
ð2Þ
where [P] and [L] are concentrations of total protein and ligand andU
and B represent signals of the unbound and bound states, respectively.
2.6. Thermal scans in MST instruments
10 μl samples of the P60A mutant of R16 α-spectrin, containing a
range of urea concentrations, were loaded into standard-treated, zero
background MST-grade capillaries to increase signal to noise ratios.
Measurements were made using a Monolith NT.LabelFree instrument
(NanoTemper Inc., Germany), as described above. Capillaries were
sealedwithwax to reduce sample evaporation. 16 capillarieswere loaded
into the instrument and intrinsic ﬂuorescencemeasured in the absence of
a temperature gradient (using a 3% LED power at 295.7 K). After each ti-
tration, the temperature was automatically ramped in 2.5 K increments
(with 15 min equilibrations between titrations to ensure equilibration).
2.7. Curve ﬁtting
Denaturant titrationswere analysedusing SigmaPlot (Systat Software,
CA). Obvious outlying data pointswere removed anddataﬁtted to Eq. (2),
which describes 2-state protein denaturation [16]. As the slopes of pre-
and post-transition baselines can vary linearly with chaotrope concentra-
tion (Fig. 1), these were variables in curve ﬁtting of denaturation titra-
tions:
F ¼ FN− FN−FDð Þ:
exp m  Denaturant½ − Denaturant½ 50%
  
=RT
1þ exp m  Denaturant½ − Denaturant½ 50%
  
=RT
ð3Þ
where FN and FD represent the slopes of the pre- and post-transition
baselines, respectively, R is the gas constant, T is the temperature (in
K) and [Denaturant]50% is the denaturant concentration at the transition
midpoint.
In experiments probing the thermal dependence of the chemical de-
naturation of R16 P60A, m was a shared parameter in curve ﬁtting but
[Denaturant]50% was allowed to freely vary at each temperature. This
allowed ΔGD−N0 to be determined at a range of temperatures. The
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Helmholtz formalism (Eq. (5)) [35]:
ΔGD−N ¼ aþ b  T þ cT 2 ð4Þ
ΔGD−N ¼ ΔHD−N  1−
T
Tm
 
−ΔCp D−N Tm−T þ T ln
T
Tm
  
ð5Þ
where T is the temperature andΔHD–N,ΔCpD–N represents the change in
enthalpy and heat capacity of denaturation, respectively, at the thermal
denaturation midpoint (Tm).
For PDZ1 F95Wdenaturant titrations, the addition of peptide caused
such a large change in stability at 298 K that the denatured baselinewas
no longer well resolved (compared to the stability of apo protein,
Fig. 5C). Thus, a common denatured baseline slope and mD–N value
was used to ﬁt denaturant titrations. All other parameters, including
[Denaturant]50%, were free parameters. Experiments were repeated at
310 K, where the denatured baselines were better resolved, with only
themD–N value being shared in curve ﬁtting (Fig. S6).
3. Results
3.1. Using MST instrumentation for sensitive, low volume ﬂuorescence
detection
We probed chemical denaturation using a Monolith NT.LabelFree in-
strument [30], which measures intrinsic ﬂuorescence emission from the
tyrosine and tryptophan residues present in many polypeptides (see
Section 2.4). Chief advantages of NT.LabelFree instruments derive from
measurements being made in disposable capillaries that are easy to
load, use tiny sample volumes and which eliminate cross-contamination
(and cuvette-washing steps normally needed when measuring denatur-
ant titrations) [31]. As 16 capillaries can be simultaneously thermostatedFig. 3.MST instruments yield comparable denaturant titrations to conventional ﬂuorimeters. Ch
titrations of a range of different proteins (Table S1). Data were acquired using a standard AB
NT.LabelFree FES axis). The sigmoidal titrations were ﬁtted to a function describing 2-state den
mD–N and ΔGD−N0 (Table 2). Whilst MST instruments yielded titrations of similar quality to co
time, operator input and sample volumes (Table 1). For the majority of proteins tested here, t
sponding denatured state. However, the reverse was true for E. coli cytochrome b562 F65W and
panying thedenaturation of these twoproteinswas inverted compared to thedata for the other
the instrument used.and measured (Fig. 2), denaturant titrations could be performed essen-
tially ‘hands free’.
The test-set we used comprised proteins with a range of folds, sizes
(4.5–26 kDa) and stabilities (ΔGD−N0 ~ 1.6–15 kcal/mol, Table S1,
Section 1.1) [8,16,24,33,36–38]. Denaturant titrations were measured
in the absence of a temperature gradient (i.e. no thermophoresis occur-
ring, Fig. 3). In this mode, the instrument acts like a ﬂuorimeter, albeit
one that uses low sample volumes (~4 μl per sample). By comparison,
the cuvettes used to make control measurements on a ‘conventional’
Aminco-Bowman ﬂuorimeter (hereafter AB2, Fig. 3, Table S1) required
sample volumes of ≥400 μl. This volume is at the lower end of those
typically employed in expert protein folding laboratories for this type
of cuvette-based, ﬂuorescence measurements (Table 1).
Manual titrations require constant user intervention to wash
cuvettes, load and thermostat samples between measurements. Thus,
skilled operators took 2–4 h to measure chemical denaturation titrations
on the AB2 ﬂuorimeter (consuming N16ml of protein solutions, Table 1).
By contrast, equivalent titrations on theNT.LabelFree instrument took just
25 min and consumed ≤400 μl of protein sample for the whole titration
(Fig. 3). Notably, the data obtained using theNT.LabelFree andAB2 instru-
ments were of similar quality and typically yielded ﬁtted parameters
within the standard error of one another (Fig. 3 and Table 2, see
Section 2.7 for details on curve ﬁtting). To test the reproducibility of the
ﬂuorescence measurements made on the NT.LabelFree instrument, we
re-measured a representative denaturant titration (here for E. coli cyto-
chrome b562 F65W) in triplicate. These denaturant titrations showed
~1–2% variance between replicate measurements (Fig. 4).
3.2. Using thermophoresis to probe chemical denaturation
Whilst NT.LabelFree instruments can be used tomeasure denaturant
titrations in ﬂuorescence detection mode (as shown in Section 3.1),
they were originally developed to measure interaction afﬁnities via
changes in thermophoresis (Table 2) [30,31]. We demonstrated thatanges in intrinsicﬂuorescence emission properties were recorded for chemical denaturant
2 ﬂuorimeter (red circles, AB2 FES axis) and an NT.LabelFree instrument (blue squares,
aturation (red and blue lines, Eq. (3), Section 2.7) in order to determine [Denaturant]50%,
nventional spectrometers, the MST measurement strategy required only a fraction of the
he intrinsic ﬂuorescence emission of the native state was more quenched than the corre-
the murine FBP28 WW domain. Consequently, the direction of the signal change accom-
proteins shownhere. This is an inherent property of these proteins andwas independent of
Fig. 4. Variance in replicate measurements of denaturant titrations. The variance in tripli-
cate measurements of chemical denaturant titrations was determined (using an
NT.LabelFree instrument) for the F65W mutant of E. coli cytochrome b562. The data
shown is the average of three independent measurements with the standard deviation
of measurements represented as error bars. The absolute variation between measure-
ments was ~1–2%.
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forming protein of hepatitis B virus, Fig. 5A). However, as HBc is dimeric
and very large (a 34 kDa dimer) compared to proteins typically studied
by chemical denaturation [10], it was unclear if idiosyncratic properties
of HBc facilitated ourMSTmeasurements. Thus, we testedwhetherMST
has wider utility for probing denaturation of smaller monomeric pro-
teins (see Section 2.5).
Control experiments using a short, unstructured penta-peptide
(AWPAK) conﬁrmed that the viscosity of chaotrope solutions had only
minor effects onMST (Fig. S2) [39]. Thus, we used anNT.LabelFree instru-
ment to characterise the chemical denaturation of SOD1 H43Y noloops
(henceforth SOD1) — a 110 residue, monomeric variant of superoxide
dismutase [40,41]. The intrinsic ﬂuorescence emission of SOD1 was re-
corded for 5 s prior to switching on the laser (creating a ~3 K gradient,
Fig. 5B). The temperature gradient was maintained for 30 s to allow
thermophoresis to proceed, after which the laser was switched off. At
all urea concentrations examined, SOD1 exhibited time-dependent de-
creases in ﬂuorescence signal corresponding to positive thermophoresis
[31]. Denatured SOD1 showed larger thermophoresis changes than na-
tive protein (Fig. 5B) despite the higher solvent viscosity of concentrated
urea solutions.
Whilst ﬂuorescence emission of SOD1 exhibited only minor, strictly
linear changes as a function of urea concentration, theMST data showed
a clear, sigmoidal transition (Fig. 5C). These data show that MST was a
sensitive probe of chemical denaturation [10], even when intrinsic ﬂuo-
rescence emission wasn't able to resolve denaturation. The wide emis-
sion bandwidth of the NT.LabelFree instrument (330–380 nm) likely
prevented SOD1 denaturation being detected by intrinsic ﬂuorescence
emission [40].
We used thermophoresis to probe chemical denaturation of other
proteins including CI2, various α-spectrin constructs and hen egg white
lysozyme (Table S1). In contrast to HBc and SOD1, however, the MST
traces of these proteins were complex and deviated from exponential-
like functions (Fig. S3). These deviationswere highly reproducible and in-
dependent of protein size, stability, topology, the presence of proline res-
idues or the size of temperature jump employed (Tables S1, Fig. S3) [8,16,
33,36–38,40]. These additional kinetic phases introduced data-scatter or
atypical baselines that complicated data analysis and curve-ﬁtting
(Fig. S3).
Further analysis revealed that the two proteins for which no anoma-
lous MST time trace phases were evident (HBc and SOD1, Fig. 5) were
also the slowest folding proteins examined [8,10,16,33,36–38,40,41].
Thus, when the timescale of a protein relaxing to its new equilibrium
position overlaps that of thermophoresis, multiple kinetic phases may
be observed. This situationmakes MSTmost easily applicable to studying
the chemical denaturationof slow folding proteins. However,MSThas the
additional beneﬁt of being sensitive to aggregates, whichmanifest as sto-
chastic ﬂuctuations in ﬂuorescence traces (Fig. S5f), providing an in situ
probe of protein integrity during titrations [31].Table 2
Thermodynamic parameters obtained for test proteins using different denaturant titration stra
Protein NT.LabelFree
mD–N
(kcal·mol−1∙M−1)
[Denaturant]50%
(M)
ΔGD−0
(kcal·
WW domaina 0.8 ± 0.1 1.90 ± 0.20 1.6 ±
Cyt b562 1.5 ± 0.2 2.20 ± 0.07 3.2 ±
Lysozyme 3.5 ± 0.5 4.02 ± 0.03 14.0 ±
CI2 2.0 ± 0.3 3.81 ± 0.06 7.7 ±
R16 α-spectrin 2.2 ± 0.3 3.32 ± 0.04 7.3 ±
R15 α-spectrin 1.6 ± 0.1 3.91 ± 0.04 6.4 ±
R16 P60A α-spectrin 1.8 ± 0.3 3.38 ± 0.05 6.2 ±
R1516 α-spectrinb 1.6 ± 0.1 4.91 ± 0.03 7.9 ±
Protein names denoted as in Fig. S6.
a The pre-transition baseline was poorly deﬁned for this protein. Thus, its slope was set to z
b The two domains of the tandem R1516α-spectrin construct unfold sequentially. However,
Thus, a 2-state equation was used for curve ﬁtting only to allow the comparison of apparent [D3.3. Temperature dependence of chemical denaturation
As discussed earlier, thermal denaturation should not be used to
study proteins that denature irreversibly, and there is also a risk of intro-
ducing signiﬁcant errors when extrapolating protein stability parameters
from the Tm to lower, physiological temperatures [3,6]. Thus, we devised
a capillary-based strategy that allowed the temperature variation of
ΔGD−N0 to be directly determined within a physiological temperature
range (Fig. 6A–B, see Section 2.6). Since NT.LabelFree instruments
thermostat all capillaries simultaneously (Fig. 2), chemical denaturant
titrations could be measured automatically at a range of temperatures
using a single set of samples and the manufacturer's software (see
Section 2.6). Chemical denaturation of R16α-spectrin P60Awas probed
by intrinsic ﬂuorescence emission spectroscopy from 295.7 to 318.2 K
(Fig. 6A). The denatured state ﬂuorescence emission decreased linearly
with increasing temperature due to increased solvent quenching.
Sigmoidal titrations were observed and exhibited temperature depen-
dent changes in [Denaturant]50%.
A Gibbs–Helmholtz expansion (Eq. (5), Materials and methods)
allowed determination of the temperature dependence of ΔGD–N,
unfolding enthalpy (ΔHD–N) and apparent Tm (Fig. 6B) [7] values. This
experiment took a few hours, but required only a few minutes of oper-
ator input and consumed b10 μg of protein. This approach deﬁned a Tm
of 332.5 ± 1.9 K, which agreed fairly well with the values determined
using DSC (Tm = 334.6 ± 0.1 K, Fig. S4, Supplementary materials andtegies.
AB2
N
mol−1)
mD–N
(kcal·mol−1·M−1)
[Denaturant]50%
(M)
ΔGD−N0
(kcal·mol−1)
0.2 0.9 ± 0.1 1.70 ± 0.30 1.4 ± 0.2
0.3 1.4 ± 0.1 2.28 ± 0.03 3.1 ± 0.1
2.0 3.4 ± 0.6 4.11 ± 0.04 14.0 ± 2.0
1.1 2.2 ± 0.2 3.87 ± 0.03 8.5 ± 0.8
1.0 1.7 ± 0.2 3.35 ± 0.04 5.7 ± 0.4
0.5 1.4 ± 0.1 3.88 ± 0.04 5.4 ± 0.4
0.7 2.0 ± 0.2 3.43 ± 0.03 6.9 ± 0.6
0.4 1.7 ± 0.1 4.92 ± 0.03 8.5 ± 0.5
ero to aid curve ﬁtting.
this behaviour is not detected in equilibrium denaturant titrations (which appear 2-state).
enaturant]50% andmD–N values obtained using different titration strategies.
Fig. 5. Thermophoresis can be a useful orthogonal probe of protein denaturation.
(A) Thermophoresis values of HBc (green circles) identiﬁed equivalent transitions to
those identiﬁed using far-UV CD spectroscopy (black triangles), consistent with
thermophoresis being an orthogonal probe of protein denaturation. Data were ﬁtted to a
3-state equilibrium transition with a populated intermediate as previously described
[10]. (B) Normalised thermophoresis time traces of SOD1 at a range of urea concentra-
tions. A 3 K gradient was created between 5 and 35 s (‘Laser on’). SOD1 exhibited positive
thermophoresis (i.e. it moved away from the higher temperature in the gradient) which
caused an exponential decline of the ﬂuorescence signal (Fig. 2). Denatured SOD1 (red
lines) moved further than native protein (blue lines). There was a gradual transition
from native to denatured protein, with both states being signiﬁcantly populated at the
transition midpoint (purple lines). Thermophoresis was reversible and the ﬂuorescence
signal returned to its initial value after the laser was switched off and the thermal gradient
depleted. (C) Complementary techniques were used to probe chemical denaturation of
SOD1. Thermophoresis values (green circles, derived from the data in b) yielded essential
identical ﬁtting parameters as far UV CD spectroscopy (black triangles). Under these condi-
tions, no denaturation transitionwas evident using intrinsic ﬂuorescence emissionmeasured
on theNT.LabelFree instrument (due to thewidebandpass emissionﬁlter in theNT.LabelFree
instrument). All curves were ﬁtted to Eq. (3) (see Section 2.7) which describes a two-state
denaturation transition.
Fig. 6.Wider applications for denaturant titrations. (A) Urea denaturation of the P60A R16
α-spectrin domain was probed between 295.7 and 318.2 K using ﬂuorescence emission
spectroscopy. The resultant titrations were ﬁtted globally to a series of independent 2-state
transitions with a sharedmD–N value (see Section 2.7). This strategy allowed determination
of [Denaturant]50% values at each temperature. (B) The parameters determined in
(A) allowed the direct determination of ΔGD−N0 values at each temperature (black circles).
The temperature dependence ofΔGD−N0 ﬁtted well to a simple polynomial equation (dashed
blue line) and a Gibbs–Helmholtz formalism (solid black line, see Section 2.7) [35]. These ﬁts
were essentially identical and deﬁned a Tm value (blue square) close to that obtained in ther-
mal denaturation experiments probed by far-UV CD spectroscopy (red plus sign, inset) and
differential scanning calorimetry (black cross, Fig. S5). (C) Assaying protein–peptide interac-
tions using chemical denaturation. The PDZ1 F95W domain was titrated into urea in the ab-
sence (black circles) or presence of either LQRRRETQV (triangles) or LQRRRETQ-Abu
(squares) peptides. The stability of PDZ1 F95Wwas increased by peptide binding,with larger
stability increases seen at 40 μMpeptide (red and blue respectively) compared to 4 μMpep-
tide (pink and cyan respectively). Inset: the relative afﬁnity of the interactionswas conﬁrmed
by thermophoresis measurements, where the LQRRRETQV peptide bound PDZ1 F95Wmore
tightly (red triangles, Kd ~ 0.9 ± 0.6 μM) than the LQRRRETQ-Abu peptide (blue squares,
Kd ~ 13 ± 1 μM).
2247C.G. Alexander et al. / Biochimica et Biophysica Acta 1844 (2014) 2241–2250methods) and far-UVCD spectroscopy (Tm= 334.4±0.1K, Fig. 6B inset).
The large ﬁtting error associated with the Tm estimated by the MST in-
strument method originated from the extrapolation of measurements
made at physiological temperatures to higher temperatures. This phe-
nomenon is, in effect, the reverse of extrapolation of stability parame-
ters from high to low temperatures (as employed in Tm-based
strategies), with both subject to inherent extrapolation errors. Extend-
ing the temperature range assessable by theMST instrument (currentlylimited to the range shown in Fig. 5), however, could reduce the extent
of extrapolations and therefore improve the accuracy of Tm determina-
tions by denaturant titrations.
However, inmany (but not all) applications, the determination of Tm
values is a prelude to extrapolating stability parameters to lower,
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is irrelevant in our strategy, since our application can directlymeasure
stability over a physiological temperature range. Whilst our control
DSC and CD experiments took similar times, they consumed ~40-fold
and ~6-fold more protein, respectively, than our capillary-based ap-
proach. Further, theΔHD–N value determined usingNT.LabelFree instru-
ments (ΔHD–N = 89 ± 11 kcal/mol, Fig. 6B) agreed better with the
value determined using gold standard DSC experiments (ΔHD–N =
79.8 ± 0.1 kcal/mol Fig. S4, Supplementary materials and methods)
than that obtained using CD spectroscopy (ΔHD–N = 66 ± 2 kcal/mol,
Fig. 6B inset).
3.4. Detecting binding events using chemical denaturation strategies
When a ligand binds speciﬁcally to the native state of a protein, the
native state becomes stabilised (i.e. ΔGD−N0 is increased) [2,3]. This stabil-
ity change has been successfully exploited in drug discovery programmes,
whereby ligand-induced changes in Tm values are used to identify or rank
hits (e.g. with DSF, Table S2) [2]. The attraction of doing this was that
uncertainties associated with heat-induced aggregation or irreversible
denaturation should be avoided, as well as the types of artefacts that
can be caused bymolecular probes (as used in DSF screens), for example:
the competition of molecular probes and small molecules for the same
ligand binding site and the dependence of apparent Tm values on varia-
tions of the molecular probe concentration [2].
The interaction between post-synaptic density protein 95 (PSD-95)
and the NMDA receptor is implicated in brain ischemia [34,42], and
can be blocked by peptides that bind to PSD-95 PDZ domains [34,42].
The peptide LQRRRETQV interacts with other PDZ domains and replacing
the C-terminal valine with 2-aminobutyrate (Abu) reduces the afﬁn-
ity of this interaction approximately fourfold [43]. To the best of our
knowledge, the interactions of these peptides with the ﬁrst PDZ do-
main (PDZ1) of PSD-95 (~50% sequence identity to PDZ2) have not
been reported. Thus, we tested if our chemical denaturation strategy
could be used to rank how these peptides interact with PDZ1 (with
an engineered F95W mutation to facilitate intrinsic ﬂuorescence
measurements).
Chemical denaturant titrations of PDZ1 F95W at 298 K produced
sigmoidal data with a [Denaturant]50% of 5.0 ± 0.1 M and mD–N of
1.08 ± 0.10 kcal/mol·M (Fig. 6B). Adding the LQRRRETQV peptide did
not affect the apparent mD–N but increased the [Denaturant]50% value
(by ~0.6 and 1.8 M with 4 and 40 μM peptide, respectively, Fig. 6C).
Similarly, LQRRRETQ-Abu also stabilised PDZ1 F95W (with 4 and 40 μM
peptide increasing [Denaturant]50% by ~0.4 and 1.3 M, respectively,
Fig. 6C). These data showed that both peptides bound PDZ1 F95W, with
LQRRRETQV appearing the higher afﬁnity ligand. The increase in
[Denaturant]50% values caused by peptide binding were so large at
298 K that the post-transition baselines were poorly deﬁned. Thus, we
repeated these measurements at 310 K to destabilise PSD-95 PDZ1 and
better deﬁne the post-transition baselines (Fig. S5). At 310 K, the rank
order of peptide binding was unchanged, but data ﬁtting was more
accurate.
The above peptides were independently determined to have Kd
values of ~0.9 ± 0.6 and 13± 1 μM, respectively, by using conventional
MST ligand-binding experiments (Fig. 6C, inset, see Section 2.5). These
afﬁnities for PDZ1 agreed well with those reported for other PDZ do-
mains [43]. Notably, the absolute changes in binding energy (ΔΔGbinding)
mediated by the Val→ Abu peptide mutation were smaller in the de-
naturant titrations (0.5 kcal/mol, 40 μM peptide) than in standard
MST-based binding experiments (ΔΔGbinding ~1.3 kcal/mol). The origins
of this discrepancy are not yet clear, but likely arise from denaturant
effects on peptide binding afﬁnities (Fig. 6C) compared to binding in
the absence of denaturants (Fig. 6C inset). Nonetheless, the chemical de-
naturant titration approach has value since: (i) it is potentially well suit-
ed to proteins that cannot be studied by thermal denaturationmethods;
and (ii) protein–ligand interactions could be detected at peptideconcentrations close to, even below, the Kd value (Fig. 6C, Fig. S5),
which signiﬁcantly reduces ligand consumption in a screening modality
(compared the10–100×Kd used to achieve saturation in classical binding
experiments, Table S2).
4. Discussion
4.1. Capillary-based instruments are game-changing for measuring
denaturant titrations
Capillary-based instruments revolutionise the measurement of
denaturant titrations. The sensitive ﬂuorescence detectors and cheap,
disposable, low volume capillaries (Fig. 2) result in low sample con-
sumption and eliminated the cuvette washing between measurements
that are normally needed [31]. NT.LabelFree instrumentsmake denatur-
ant titrations easier, faster and consume several hundred-fold less pro-
tein than conventional approaches used for measuring denaturant
titrations (Table 1), yet our approach has no compromise in data quality
compared to thesewell-establishedmethods (Fig. 3, Fig. 4, Table 2). Left-
over materials from other experiments could also be used for capillary-
based denaturant titrations since only ~4 μl samples were needed
(Fig. 2). These advances transform chemical denaturation from a labour
intensive method into a mainstream tool likely to have widespread im-
pact on multiple applications in academic and commercial arenas.
We show thatMST instruments allowprotein chemical denaturation
to be monitored using both ﬂuorescence emission (Fig. 3) and thermo-
phoresis (Fig. 5, see Section 3.2. It is unsurprising that thermophoresis
is so sensitive to protein denaturation (Fig. 5 and Fig. S3) since it reports
on factors affecting the solvation entropy of proteins [32]. Being able to
simultaneously acquire two orthogonal probes of chemical denaturation
is convenient and potentially very informative (as for SOD1, where no
denaturation was observed by FES, yet denaturation was very clear
when MST was used, Fig. 5C). However, the timescale that proteins
relax to their new equilibrium (i.e. from T1 (laser off) to T2 (laser on),
Fig. 2) can be faster, slower or overlap that of thermophoresis [22].
Where the timescale of folding and thermophoresis overlap, one can ob-
serve complex kinetic traces that make data analysis challenging
(Fig. S3). Thus, thermophoresis has most value for probing the denatur-
ation of slow folding proteins and we recommend that the decision to
use thermophoresis be judged empirically, cognisant of these potential
complexities. Fortunately, thermophoresis data can be obtained with
very little extra effort (Fig. 5, see 3.2).
Using MST instruments to measure protein stability can certainly
help accelerate programmes involving extensive protein engineering
(e.g. protein folding studies, directed evolution and protein design).
Such programmes are often costly in time, manpower and materials.
Our ability to solve the protein folding problem is currently limited by
the number of proteins for which extensive experimental data exists
[9,44]. The strategies reported here allow the folding properties of
manymore protein variants to be characterised, since stabilitymeasure-
ments are now easier, faster and cheaper (as protein production can be
down-scaled signiﬁcantly, Table 1).
4.2. Using one instrument and orthogonal approaches to characterise
molecular interactions
Drug-discovery programmes are exacting and demand high
throughput, low cost, low material consumption and robust ranking of
hits. ITC is the gold standard approach for the accurate determination
of Kd values, and sometimes interaction enthalpies [6,45]. Unfortunate-
ly, even robotic ITC platforms have limited throughput and consume
large amounts of protein and ligands (Table S2).
Alternative techniques, including surface plasmon resonance, ITD
and DSF, can achieve much higher throughput (up to 7000 interaction
measurements per person per day for DSF) but these approaches usually
require protein immobilisation, high temperatures or the use of extrinsic
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conformation can — albeit in a minority of cases — cause artefacts or
perturb the protein or interaction being studied [2].
We showed that our denaturant titration strategy was sensitive to
protein–ligand interactions and could rank them by afﬁnity (Fig. 6C
and Fig. S5, see 2.4). Thus, NT.LabelFree instruments are able to detect
a protein–ligand interaction by two orthogonal means; (i) from
ligand-induced increases in [Denaturant]50% and ΔGD–N values (Fig. 6C,
Fig. S5); and (ii) binding titrations probed by thermophoresis [30,31]
(Fig. 6C, inset and Fig. S5). In standard MST binding experiments, how-
ever, ligands are diluted from concentrations of 10–100 × Kd (Table S2).
By contrast, in denaturant titrations, ligand binding could be detected at
concentrations around, or below, the Kd. This signiﬁcantly reduces li-
gand consumption and allows low solubility ligands to be studied
(both of which are attractive for screening modalities).
The excellent complementarity of these strategies allows compound
libraries to be initially screened using chemical denaturant titrations and
emerging hits to be conﬁrmed and ranked using MST ligand-binding ti-
trations. This should help reduce the incidence of false positives whilst
requiring an investment in only one instrument. Since extrinsic label-
ling, molecular probes or immobilisation are not required, our strategies
do not perturb proteins or their stability [10,19]. As high temperatures
are not used, these strategies appear to be suited to tricky protein targets
that aggregate irreversibly in conventional assays employing thermal
denaturation methods [1,2], although this still requires veriﬁcation.
4.3. Potential commercial applications
It is possible to use NT.LabelFree instruments to measure 25–50
chemical denaturant titrations per day (compared to 2–3/day using
conventional, cuvette-based methods, Table 1, Table S2). However, the
chemical denaturant titration strategies we report are fully compatible
with front-end liquid-handling robotics for dispensing titrations.
Indeed, decoupling denaturant dispensing from titrations is essential
to ensure complete equilibration of samples prior to measurement.
Using robotics with the recently launched Monolith NT.Automated in-
struments permits further increases in throughput— two 48-point dena-
turant titrations can be measured in b8 min. For screening purposes, a
lower data density of 24 points/titration is acceptable (Fig. 6A) and allows
a single user to measure 576 titrations daily on one instrument. Whilst
this throughput does not come close to that of high throughput screens,
it nonethelessmeets the throughput andmaterial consumption demands
ofmanymedium-throughput screening applications (see Table S2), espe-
cially those in academic labs where compound collections are generally
much smaller than in pharmaceutical companies (e.g. focussed libraries
or fragment collections). Thus, we see the methods described here as
likely to be most applicable to targets that cannot easily or robustly be
characterised using current prevailingmethod (for the reasons described
earlier, see Sections 3.4 and 4.2)
These methodological advances are likely to make chemical dena-
turant titrations more relevant to pharmaceutical research. Clinical
antibodies and biotherapeutic proteins form an increasingly large pro-
portion of the drug-discovery pipeline [2,46,47]. Pharmaceutical compa-
nies need to formulate expensive biotherapeutics so that they are
stable, do not aggregate and reach points-of-care intact without altered
antigenicity or activity [1–3]. However, biotherapeutics can be aggrega-
tion prone at high temperatures, for example the anti-EGFR monoclonal
antibody, a potential cancer therapy [1,3]. This can make it challenging
tomeasure the stability of such therapeutic proteins using thermal dena-
turation [3,48]. Using capillary-based instruments combined with chem-
ical denaturation, a single user can rationally optimise storage buffers,
additive and temperatures quickly, whilst using very little material.
The sensitivity of MST for detecting aggregates provides an internal
probe of protein integrity throughout denaturant titrations (Fig. S3F).
Few routine techniques have this capability, especially in higher
throughputmodalities (Table 1) [31]. A particularly relevant applicationfor our strategies is to screen for small molecule chemical chaperones
that stabilise target proteins and concomitantly re-establish their
biological functions [12]. An important target, the tumour-suppressor
protein, p53, is mutated in 50% of all cancers. Many mutations
destabilise p53 and cause it to aggregate, with concomitant reduction
or loss of function. Our strategies have clear utility for p53, where a
single experiment could yield insights on the aggregation state of p53
and its stabilisation by small molecules.
4.4. Conclusion
The combination of sensitive ﬂuorescence detectors, low volume cap-
illaries, thermophoresis detection, and automation makes NT.LabelFree
instruments extraordinarily versatile. Using a single platform, scientists
can now characterise a protein's stability and ligand interactions by or-
thogonal means (thermophoresis and intrinsic ﬂuorescence) with high
accuracy, over a range of temperatures and free of extrinsic labels (with
the option of probing aggregation phenomena). The hardware allows
for instant switching between these modalities without needing exten-
sive experience or training. This versatility suggests that the methods re-
ported here canhave an immense impact on protein researchwithin both
academic and commercial communities [30,31].
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